Interim report
Page 1
Poly Medicure Limited ) :»iPOLYMED Regd. Office: 232 B, 3rd Floor, Okhla Industrial Estate, Phase-Ill, New Delhi - 110 020 (INDIA) T : +91-11- 33550700, 47317000 E: info@polymedicure.com W: polymedicure.com CIN:L40300DL1995PLC066923 ... Date: os•h November, 2026 Scrip Code: - 531768 The Manager, BSE Limited, Department of Corporate Services, Phirozee Jeejeebhoy Towers. Dalal Street, Mumbai- 40000 I. Scrip Code:- POLYMED The Manager National Stock Exchange of India Limited Exchange Plaza. Plot No. Cl 1-Block-G Bandra Kurla Complex. Bandra(E). Mumbai -400051. Subject: Outcome of the Board Meeting of the Com panv Ref: Compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 20 I 5 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR ) Regulations, 2015. We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. OS'h November. 2026. at at 232-B. 3rd Floor. Okhla Industrial Estate, Phase-Ill. New Delhi - 110020. approved the following businesses: I. Financial Results a. Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30'h September. 2026. A signed copy of the above Financial Results (Standalone & Consol idated) along with Auditors ' Review Reports thereon is attached herewith as "Annexure - A" 2. Classification of Polv Medicure B. V., Netherlands ("POLY MED B. V. ") as Material Subsidiarv of the Company. In terms of Regulation 16( I )(c) read with Regulation 24 of the SEBI (Li sting Obligations and Disclosure Requirements) Regulations , 2015 (the ·'Listing Regulations'') Poly Medicure B.V .. Netherlands, a Wholl y Owned Subsidiary of the Company. has been identified as a Material Subsidiary of the Company. as its Net Worth has exceeded 10% of the consolidated networth of the Company. Acc ordingly. the Company shall ensure compliance with all applicable regulatory requirements prescribed under the L isting Regulations in relation to Material Subsidiarie s. The Meeting was started at 11 :30 A.M. and concluded on 2:00 P.M . Kindly take a note of the same for your further needful and obli ge us. Thanking You. Your s Sincerely For Poly Medicure Limited A vinash Chandra Company Secretary M. No. A32270 Plants : Plot No. l 04-105 & 115-116-117, Sector-59, Hs11dc Industrial Area, Ballabgarh, Faridabad - 121004, Haryana (INDIA) Plot No. 33-34, Sector-68, IMT, Faridabad-121004, (Haryana) INDIA T:+91-129-4287000, 3355070
Page 2
POLY MEDICURE LIMITED )POLYMED 1te9<1. Office: 2328 3rd,._ , Olchll -•- PllaM 10. - Oolhl • 110 020 Webolll!: www .polymodlcure.a>m, E-mail: ln-...:■ reOpolymedlcure.c:om, O N: L◄0300Dll995PI.C061i923 STATEMENT Of UNAUOrTED STANDALONE AND CONSOUDA TE.O FINANCIAi. RESULTS FOR TitE QUARTER AND HA1.f VEAR ENDED SEP'TE.MIER 30, 2021 (~ In loa uceot ,., share chtal -- ~ - ConooUdlttd Panlcularo Quarter Ended H•II Yeor Ended Quarts Ended Hall'Y• r Ended y-- Year Ended 30.09.2026 30.06.2021 30.09.2025 30.09.2021 30.09.2025 30.ot.202' 30.06.2021 :11.09.2025 30.09.2026 30.09.2025 31.03 .2026 31.03.202 1 ,. __ flk-tacfl lun.udltacfl fl.11-- l rtJ-tedl CUMudltlldl ,_, (- tall /Unaudited} (AuMod ) (AudllJOd) 1 -I -....rrom- 48,827.62 43 10!195 ◄ l,65U7 91937.57 80.fl5&84 58 052.58 52 537.SS ◄◄.388.16 110590.11 84,709.23 166246.48 1,87 525 92 b Other lna>mo :1.0◄3.66 t863.6◄ 3.1n.10 ◄ 907.30 7,524.36 1 900.93 3,339.58 3 .lCl◄.43 5 2◄0.Sl 7 606.23 11991.77 12.00822 To«al I_,,. IA} 50,171.28 , 5,973.59 '5.026.27 ,.......,7 17,583.20 59 953-'9 5 5,17 7,ll 47,11l-59 1.15,13CU2 9 2,3U M 1.71231.U 1.99,n.4.1 4 2 ,-- • Coltd -■ mnsumod 18,226.92 15 27460 14431.91 JJ 501.52 27-'Wi77 20156.91 18.387.50 15706.96 38-~ .41 29 81◄.31 531111<,50 59938.70 b ~"'5d ltlldt·- 85.66 177.12 123.◄2 262.78 209.27 159.50 267.46 123.41 ◄26.96 20!1.27 SOJ.71 506.05 C ,.,,.._In..,._,.,, ar finllhod goods, wort<-n- oro 5'llXl<·ir>tnlOI! (3,115.97 C3 l n15l (1946.24 (6 288.121 (2.701.52 (2,953.39) (4,680.08 (2.16◄. 58 (7633 ◄7 13.T.l◄. ~ ( J 1lQ_64 (763.63 d Em~bet'tef 1S~ 9 565.15 8,89080 8 182.98 1 8 ◄55.95 15 104.38 13 037.3◄ 12.690.29 8 775.◄9 2SnHl 16 215.23 31 31◄.62 4'225 .59 • _,.., 835.67 78801 875.li) I 613.68 l 601.50 836.43 789.11 876.◄J 1,625.5◄ 1604.89 VJIIJ.30 Z,987.59 """'1cea,,t m.n ◄38 46 178. ◄0 838.18 559.78 714.91 650,l ◄ 297.27 1 -,05 592.28 I J◄J.32 t,12' .07 a Doc,roc....,,, Ind """'11saton - 2,725.90 2,6◄ 700 2,◄26.35 5.Jn90 ◄,721 84 3 ""'.89 3 625.28 2 V\4.44 7 130.17 4,841 ◄6 9 1119.82 11,55166 h Other- 9,8◄0. 71 9065.8 1 8"".65 18 906.52 17 274.17 13 059. l◄ i, .. n19 9 59062 25631.D 18 538.0◄ )◄, 291.11 ◄D .399.97 TOtll --Cl l ~-•715 3',109.65 ll.225 .67 72.673.,1 64,076,11 48 515.73 ◄4301.H l5 710.05 92.&17.62 11,0I0.73 1.32.761.7' 1.56675 .00 3 Profit before share of omllt ofMIOdo te, .. .-.-11tom ■nd tax (A·l l 12,307.52 11,863 ,M 11,100,60 24,171.46 U,507,01 11,43 7,76 11,575.24 12.072,54 23,013.00 2-4,23◄.73 '5.'61 ,51 42,159 .1, ◄ Shirt of Pror~don ossodale 151.65 155.D 96.◄9 306.98 228.92 561.37 ----M ltlom ond QX 1>=1.52 1U63.M 11.I00 ,60 2◄ 171.'6 23 507.01 1 L589,41 11.730 .57 12.169.03 23.319 .91 2,...,, .,s 45 £0.51 43A27 ,51 5 --1- Imna-1d Lobour ,,.,,,,., RM'oeasurementd,...,,,,,_.CXlRSlderotlon (956.21 (956.21 6!0.40 680 ◄0 6 Prolltbeforotax 1>=7.52 11.163, M 1 ..AUU.60 24,171.46 U,507 .01 12.545.62 11.730 .57 12.119.03 2' 276,lt 24,463.6 5 44 719.ll 4:Z,747 ,U 7 TIX ftnl!ftW • wmn:tax 2,739.65 :1.506. 7◄ 2,651.16 5 246.39 4 782.74 2,914.11 2,816.11 2 7<6.63 5 730.22 4,953.◄5 9 657.70 JO 115 84 b Do!em,dlaX 365.37 S'IJ.91 243.79 909.28 1 026.JJ 118.93 386.07 2◄2. 65 SOS.Ill 1,022.19 1,501.75 528.ll C r.arJ!«'yeDr"tzlXel. 0 96 0.96 096 0.96 J0.17 30 17 T_, tax_ 3,105.02 3, 051.61 2,195.55 6156 .63 5,809 .07 J,033.0◄ 3,203.14 :un.21 6 236.11 5975 .64 11.190.62 10,174.12 8 Profit after IH 9 202.50 1112.33 I 905,05 11014.83 17,697.M 9 512.58 I 527A3 9 179.75 110◄0 .01 ll~.01 33591.4 9 32,072.'9 9 Other comnr11tienli Ye Income I!JfflS lhot w~ not be """""'""' to - ~ or ""' : R.em ein1.0! tn8\ts d deffleO beneht C101011t10nS 91.()8 (90.9◄ D.65 0. 1 ◄ (83.o 91.08 (90.94 )3.65 0. 1 ◄ (8367 :J0.23 30.23 r■x i._..onatxM! 122.93 22.19 18.47 10.04 21.06 (22.93) 22.89 18.47: (0.041 2l.Cl6 (7,61 (7.61 It.ems tMt witl be redassified to pref rt or loss 11 sub9eCt,.lent IJ"Cf""": E>cchange d,(f,nnces on -of flnandal SIBte_, ts d f0l1!iQn Su-ies (209.18) 63.n (49 57) (145 45) (JO.SO) 4,62597 Toxlmpaason atxM! TotJtl other com-,rw Income 61. 15 (68.05 25.11 0.10 (62.61 (141,03 C..32 (24.3 9 (145.35 (93 ,111 22.62 4 641..59 10 TolJII compre/lMlllve Income (compr111lng proflt ofter tax and othe, 1-------11- , ... ___ --- •--' 9,270.65 1,744~ 1 1,930..23 18,014,93 17,635.33 9,371,55 8,S2J-,11 t ,155.36 17,IM,66 18,394.90 33,6Zl.U 36,721.51 11 Net ,,,..,.,t ~ to: ·~ ..... hoidier'Sd thel1illrfW'II. - g,512.94 1,602.52 t ,113.50 11,115 .'6 11,491 .76 32,213 . K Non-<D'l- liurests - (0.36) (7509 (3,75) (75,451 (3."' Cl ◄09n 12 other comprehensl\tt! income attributable to: ,.-..rvl'ddln d lho,,._ (139,991 (◄.3 5 (24.39 ( 144 . 3◄ (93.11 4,651 .69 lntwests (1.04) 0.03 (I.DI - (H''I 13 Total .....__.,ve lna>me atulbu~e to: ~ •·~l'dden d lho- 9 372.95 1,591.17 t,1 59.11 17 971.12 11,391.15 36,865 .64 ·- lourests (l.◄O (75,06) {3.15) (76.<6) (3,751 (I ◄◄ 116 l◄ , ......., OQUltY ""'~ ,.,.,... (Faot Valued ' 5 ead1l 5 068.07 5067.97 5 067.97 5 068.07 5 067.97 51""1.07 5 067.97 5067.97 5 068.07 5 067.97 5.06797 5 067.97 15 -....exQldn;j - --.. perbolonoe- ~pr-.,, acau,tr,g 3,15,104.42 3.00,203.27 3,05,549.:JO 16 Ebmh'K; oer stwe. m , artertv not annuefised) : -Basc" l 9.08 8.69 8.19 17.77 17. ◄7 9.38 8.◄9 9.06 17N l,.~ " 3315 31.19 Dikm H O 9.07 8.61i 8.78 17.75 17 . ◄5 9.37 8.◄8 906 U.I<S ~nn~ '' JJJ2 31 15 (l~ ~ ''08~-- vo6'_.,. ~ o u. -::i. rn . ~ 1 ~ New Deihl r 1) J ~lewCeJ ~ CJ <:' ~~ .;,,,./, ~•!>" 9redAcc o'i>~ --
Page 3
(Un Laa) Sb-of--~ : I - ~ As ot 30.09 .2026 Ant Asillt 30.09.2026 Ant - 3LOJ,2026 3LOJ.2026 (Unoudltad) ,.,..., .... ., (UllitUdltad) , ..... ,....., ASSCTS I --I 1nc1~- 1.24 895.37 I 20011.88 I 34 996.05 125.51 5.09 ·--·- 10,983.28 9031.40 ID 968."9 9.051.37 C •-ofu.e- 174.90 297.73 3150.17 795.65 _. on ""'50lldotlon 31,572.65 31,369.99 e I IM:MVSil:)6e 11:SetS l.304.89 1381.01 15 432.96 15 709,"8 Jntanolb6el5RICSl.l'ldlr'~ 612.47 553.13 989.80 820.14 al flnlnoalAa!ts '.I) lnYOStmont In SUCOldior1-'as,odooes 53 061.49 50,329.74 l 565.02 1.517.19 ri)OlherlnYl!slments 1263.51 f,0,54 1263.51 60.54 (IH)Othorlinlncloll5MIS l,IM0.34 l 806.30 1,853.65 I .IIW 33 (hl Oolerred tax - 31148.14 3 652.59 I Olher non-curront - 6 337.64 7.559.07 6,586.98 7611.04 TOGI non-awrent aAlltl 2.00473 .19 LtL037.-0 2.12.227.42 L97963 .01 2 Current ■IMD <• - 34 586.71 28,13".34 51,217.67 43.384.07 fb flnlnoal.-. n- 71806.55 73 915.75 71,806.54 73915.~ •1 Trade receMlbles 47 431.26 44 224.73 55.B!l!lU 53117.27 Ii) Cosh and QSh- 769.70 593.81 511>1l.19 5122.82 IV)l!onkl!alonces-thon(lil}- 3 992.98 3 664.18 4 137.98 3664. 18 y) Loons 496.43 70.95 68.45 74.43 yj) Olher fnanclol aosets 4M<!l0 4.075.34 l 024.8' 4 270.36 kl Olhera,rent- 12,071.49 9,27799 13,337.92 10 344.114 fdl Cla'rent:TaxAssetsCNetl T~a,rrentHNts 1.75 251.02 163 957.09 2,03,302 .33 l 93,193 .71 TOTAL ASSETS 3,75 724.11 J,54,"4.89 4,15,529 ,75 3 91,156 ,72 EQUITY ANO UABILITTfS EOLITY Cal I FnuiN 5/'W'I rAnltal 5,068.07 5 067.97 5,068.07 5 067.97 (bl Olher~•- 3 15 104.42 3 00 203.27 3 21 "66.84 3 05 549.30 Eaul ty •ttrfbutlble t o lhareholde11 of die comoonv J ,20,172.49 3 OS 271.24 3,2 6,534,91 l 10,617.27 Non-controlllna lnteroot 4,230.59 4,307.05 Tobi t eaultv 3,20, 172..49 3,05,271.14 3,30,755.SO 3 14 924.32 I UABILJTIES l ---(I) flnlnoal- 1)- 21.51 252.81 3.910 93 5 208.77 •llelsellll>iities 62.02 92.53 2.630.01! 516.11 ,., Olher rononc11 - 71.49 77.Jl 2.316.25 J 593.35 (b OlherNa1""'"'1tllobllibes 806.39 I 000.75 (c) - 1 430.65 l 420.75 3,385.56 3 106.70 fd} GoYsnmen!Gran!s 60.52 156.05 61.58 157.58 !el Delemid tax 1ab11 oes (Nell 6 706.23 5796.90 6 725.24 5.796.~ Total non-cum,nt t11bltltles 1,352 ,42 7 796.JS 19,836.03 19,380 .16 ~
Page 4
l cu ....... 1_11_ (al froal-oal- 't) 6orTOw-- 28,242.21 MS9J.14 )) 803.53 28 952.98 Ill lase Ulbl 1Ues 128.66 226'!6 IHI 14 679 73 111lnede:n1t.,_ al IIDtll""-ci.-olmoo-and small---- 975'19 I 596.58 975."9 1596.58 b\ mtil ,..-dues d aedllas cxherthan moo- lf'ICI 8,599.39 6.87U7 12.293.)7 10 669.93 Sfflll1 ~ (,v) Other f...-aal - 6.381.15 5 745 78 9.831 "9 a 89-1.oe (bl Other cur.nt loblibes 1,661.55 2.31).08 5 Sil.IS 56<2.95 (cl Pn:Molons 45.71 23.79 45.71 256.0) (dl Cl.rrwltTIX llll>..,..( Net) L165.&< 557.10 1624M 859.96 TOAl Cunw1t Ulllllltles 47 200.DO 4L927 .JO 64921.22 57,552.24 TOTAL FnllI~T ANO LJAll.LmfS 3,75,724.91 l,S4,9M.19 415 Slt.75 3,91,151.72
Page 5
c.111 ,_ Sbtement for the half - .-30 -mber 2025 Standalone ConlOll~ ted - HolfY-ondod HolfY-ondod 30-ber2025 30-berl 025 30-.--2 02, 30---. ,-.2025 UIIOIN!lted Utwtudlted Unaudited IJnouclted A CASH FI.OWS FROM OPERATING ACTIVTTlES l'rolltbeforelax 2<4,171.<6 23,507.01 2<4,276 19 2<4,463 65 Alljultmdfar. --ond- 5,Jn.90 ◄,nl. &I 7,13(1.17 ◄,841-% si..1n L_,,. lrom ~ . ()06.98) (221l92) l-- 138.18 559.78 1,365.05 592.211 OMdonl lnamt/- cx,ur"d ,,_ (318.95) (1.07) -- (250.~J (699.51) (250.~ ) (699.Sl ) 1.-'(prcftl) en -s,:/d/ dsarded 0.80 ◄3. 87 7.98 ◄3.87 Dlbttl-wrltlllnolf 2330 26.27 23.30 26.27 Pn,,,.51on for doul>lful - ond ac!Yanal,; 11.()6 50.28 91.22 50.28 OWi< bolln:. no ~ re<JJ,red, Wl1ttal bid< (16.2<4) (19.23) (16.2◄) (19.23) Offlrred ~ COIT1)0f1Abon-- (net) ◄31.93 312.◄8 ◄31 . 93 312.-18 l.mllllSed linq, """'- (gain) /tJ5S 1,006.31 (694 80) 1,006.31 (694.lll) --ond ...- (Ga11)/l.<la on MIAulJ l'\.nd (2.7-48.69) (4,21◄. 16) (2.7-48.69) (4,214.16) Other~- Ind "5 ll Other od}u&m1onls (171.09) (130.92) (282 65) (2◄3.74) Elfec:t of foreogn t>dw,nge ,_cn _ of Ql)WOtfng cwlloYis (537 04 ~ profit - worldng capital cllonges 21,350.57 23,462.90 30,119.07 24,229 .'3 - In -1dng capitol ~~)In-- (6,452.37) (2,881.59) (7,833.59) (3,905.02) OOC,-, (incn!ase) In Trade - (4,326.12) (4,602.07) (3,970.58) (4,997.57) ~(lncnlose) In finendlll asielS 24468 23079 232.06 88.31 OeaeM,/(lnaeose) ., Olhor assets (3,503.67) (556.23) (3,182.80) (Jn.63) ,,.,.,_..., (docTeose) ., b1ldo ~ 1,211.34 1,80< 08 1,092.20 1,895.09 lncreas,/ (--) ., Olhor fW11ndao loabo ltles 92573 (2,673.15) (92.18) (5,127.09) lncrYW>' (docTeose) ., Olhor - (960 ◄1) (1,106.51) (635.08) 1,411.33 lnc:reos,o'(--..se ) npn)WlonS 31.96 159.79 68.69 309.07 CHh ~ from operations 15,521 .71 13,831 .02 15,867 .79 U ,526.Jl 0... taxes pilod (net of notunds) (◄,638.611 (◄ 233. ◄9 1 (◄ 966.901 (◄.381.861 Net cash from open,ting octfvt1leo (A) 10,813.10 960◄ .53 10,900 .19 9,144.26 9 CASH FLOWS FROM INVESTING ACTIVITIES l'ulttll,o ol fixed asseu (ln<:Ui,ng c:a:,,tal acMlnCes) (10.788,01) (15, ◄59. 2 5) (12,428 68) (15,733.12) 1"""51mont n subsidiary Paymenu - l>Jswiess -,lslbon (net of cash aod cash eqolvalonts acq\Jirf<l (2,731.75) (16,931.20) _, bus ..... acquls,tlcn) (29.65) (15,059.34) Advora paid ID subsidiary (9.25) Amcult pood under resolub:lnplan l)lmil,g o--..o1CX>n1To1 (3,316.00) (3,316.00) (l'l.rdlaso)/Sole d awmtt lffleltmems (net) 3,6◄2.28 19,325.02 3,6◄2.28 19,325.02 Proceeds ,-/ 0-n) Fbed 0.C,0,.1> (net) (347.46) 2,158.97 (347.46) 2,158.97 Proa!edsffOff' sale of""-'fplo,t and_ &_p,opert,es S.66 -<◄ 7◄ 45.28 -<◄ .74 DMdond lra>mll/gc,,,,,nmg cnrdl vere 139.18 13918 -- 167.52 28274 167.52 282.~ Net cosh used for Investing octMdeo (BJ (9,921.13 ( 13,894.91 Cl 811.53 (12,296 .99] C CASH FLOWS FROM FINANClNG ACTIVIDES J>nx,eds from (""""""1ent l ol borrowlnos / deferred POvment lioblllbeS (net! 3,386.52 5,256.76 3,457.26 5,586.00 J>nx,eds from Share Aliotn"elts ESOP 1.98 33.78 1.98 33.78 Repayment of Lese l.lablWes lndudJro lnJe<8St (140.28) (130.88) (570.53) (130.esJ OMdend Paid (wd..dlng ..-.cle,mod dMdet-d ttansferted) (3,229.13) (3,229.13) lnter!JSt/ Flnitnce cha,ges paid (B0<.47 (532.•"' fl 075.73 (562.561 - cash lroo, /(uoed lor) finondng •cthritles (C) (795 .39 4, 627 .00 U,416 .1.5 ◄,927 .14 l,et - (-) In cash ond cash t!QUMlis>ts (A.,B+Q 175.89 336.SS 673 .21 l , n◄ •◄ 1 cash and cash equ,volents at lhe belJWVWl!I of lhe - 593.U 54.15 5,122.S2 869 .H Ellor:t of """9> ooc:hir,ge race dww"9l!S on cash and cash OQUlvolents hold n fcnlgn cum,ncv 2◄. 75 Cosh and cast, equivalents at the end of the period 769.70 391.40 5,120 .79 2,644.30 COMPONENTS OF CASH AND CASlt EQUIVALENTS Balonoes with Banks In cum,nt ocm.nt 759.22 381.73 5,806.80 2,624.41 Cesh on hand 10.-18 9.67 13.99 19.83 CUh and ca,1, eqwvalenU •t the encl of the period 769.70 391.40 5,120,79 2.644,30 • ~ Noc9:,., abo,est,ternentof cash llow hos- JnlJlll-ed under lnorect melhod IS set 01.t In U.OloS--7 "Slalementd Qlsh Flow" " - - - J
Page 6
Notm: The abolle unaud~ed standaone and consohdated resulis were reviewed and recommended by the Audit Committee 8. approved by the Board of Directors at their respedM! meebngs held on 5th Noverrbe', 2026 and have also been lmled reviewed by the st.lt\mty Mldlttn, ,~ the Company, The statutory auditors have expressed an unmodified review report on these standalone and ooo ISOldlted finanoal results. 2 The standalone and consolidated finanoal results have been prepared In accordance with the pnnoples and procedures of Ind an Accounting Standards ('Ind AS') as notified under the Companies (Ind~n Accounti119 Standards) Rules, 2015 as sped'ied n Sl!Ctloll 133 " ti' ,e Corrpanies Ad, 2013 3 The consoldated flnanoal results of the company and its tore,gr, subsdaries/lndlan subsoclia,y ("G'oup') and assoo,te have been prepared as per IND AS 110 'Consolidated Flnanoal Statements· and IND~ 28 on •investment in Assodates". The enblles whose financial statements have been lnduded In corsolodated finanaal statements are as annexed. 4 In hne with the prov1S(OllS of Ind AS 108 "Operabng Segments• and on the baSIS of review of operations being dcne by the management of the company, the opera-Ions of the group fans under medical devices, which is considered to be the only reportable segmert by ltl,e management 5 During the halt year ended 30th September, 2026, Polymed Brazil LTDA, a wholly owned subsidi.ary company has acquired 100% equity in Medyneo Cometdo De Produtos Para Saude LTDA at a total oonslderabon of, 34 OS lacs effective from 29th April, 2026. 6 Dunng the prev,oos year ended 31st March, 2025, the company had ISSUed 53,19,148 equity shares d, 5/· each at premium of, 1,f!75/- each (issue pnoe per share, 1,880/· each) amounbng to l 99,999.98 lacs to Qualified InsbtutK>nal Investors on Q[P ~ and alOlrnet-t was completed on 22nd August, 2024. The proceeds of QIP have been uliUzed as per objects of issue and the unutll sed amount of , '40,421.43 lacs have temporanly l>eel invested in liquid mutual funds/FO/bondS and balance amount In QIP acrount is , 7.10 lacs. 7 The Conso !dated flnanaal statemer,t for the quarter and half year ended 30th September 2026 includes , 956.21 lacs towards derea>gnillon of fair value of conbngent consideration paya~ by one of !he step-down subsld,ary to the Selling Sharet-older r:A the 'Pendrac.ar el GrOLp". This derecognition was on account of non-acheivement of the agreed milestone for earn-out payment as agreed under the Share Purchase Agreement This event being the event after the acqulsllion date, hence the liability derecognised Is dasslfied as an exception-a Item. Dunng the quarter ended 30th September 2025, M/s Poly Medlcure BV, Netherlands, a wholly owned subsidiary company of the Company, acquired 90% controllirg stake in RJsor Holding B.V, Nethet1ands for a cash CXlnSlderation of , 14,825.77 lacs effecbve from 23r c September 2025. Dunng the period ended 30th Sept.ember 2025, this transacbon was accounted for ,n acmrdanoe with the acqulsrtJoo method. The Purchase price alocabOn which was eariter done on a provlsiOnal basis, was finalised In quarter ended 3~ September 2021 accordingly, the amount of goodw,n and other recoverable have been inter--se adjusted retrospedJvely by, 267 56 lacs and goodwill as on acqu1S1ron date is restated to , 16,395.13 lacs Dunng the quart,r ended 31st December 2025, M/s Poly Media.Ire BV, Netherlands he , acqllred 100% stake 1n Med!Slream SA, Swrtzer1and for an upfront consideratlon of, 24,322.83 lacs and lhs transaction was aocounted In a<XDrdance with Ind AS 103, 'Business Combinations" Remeasurement adjustment In amount of goodwH and defem-ed tax asset has bee earned out and the amount of ooodwil is retrosoectivelv carried at , 9. 782.58 lacs and deferred tax assets at , 2.533 59 lacs on acou1sition date. 8 Upon consolidation of Himalayan Mineral Waters Private Limited, effeaive 1st April 2026, the excess of fair value of assets aaiulred over the total consideration paid in respect of Himalayan Mineral Waters Private Limited, amounting to , 1,277.61 lacs have been taken as eop,t ~' reserve as on 1st Apnl 2026. 9 Previous period figures have been reg 'OUped wherever necessary to conform to the current year dassmcauon 10 The unaudited results of Poly Medlcure Limited for the qcarter ended 30th September 2026 are available on our web6.te, www.polymedicure.com and on the Stock Exchange website www.n; and www.bseind~ com. P!aoe : New Delhl HlmanlltuBal cl Date : 5th Ncwember 2026 Ma I Olrecblr
Page 7
List of entities included in the consolidated financial statements for the quarter ended 30th September , 2026 are as und er: Sr. No. Name of the Company 1 Parent Company Poly Medicure Limited Subsidiary Plan 1 Health India Private Limited111 Poly M edicure (Laiyang) Company Limited (l l f +- i Country of Holding as on Holding as on incorporation September 30, 2026 March 31, 2026 + t 100% 100% 100% 100% 2 3 4 5 6 7 ! Pcm, Medicure B.V.111 Polymed Brazil LTDA(ll Himalayan Mineral Waters Private Limit ed(1l ! Step - subsidiary Plan 1 Health SRI (ll 7 India China Netherlands Brazil India Italy 100% 100% 100% 100% 100% 100% 90% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 8 1Risor llold ing B.V. 121 9 Wellinq Medical B.v.<3l 10 Pendracare Holding B.v .131 11 Pendracare Vascular s .v .!•l 12 Pendracare International B.v.<•l 13 Medistream SA<21 14 Citieffe SRL(S) 15 Citieffe lnc.'61 16 Citieffe De.<61 17 Pol Healt h lnc.<2> 18 Poly Healt h Limited'21 19 Medyneo Comercio De Produtos Para Saude LTDA1' 1 t Associate 20 !u lt ra For M edical Produ cts Company (Ultra Med) (I) Wholly-owne d subsidiary of Poly Medicure Limited 12> Wholly-owne d subsidiary of Poly Med icure B.V. <3> Wholly -owned subsidiary of Risor Holding 8.V. <•J Wholly-owned subsidiary of Pendracare Holding B.V. (SJ Wholly-owned subsidiary of Medi stream SA (61 Who lly-owned subsidiary of Citieffe SRL < 7 l Wholly -owne d subsidiary of Polymed Brazil L TDA Netherlands l Netherland s Netherlands Netherlands Netherlands + Switzer land Italy USA M exico USA UK Brazil Egypt t 23% 90% 100% 100% 100% 100% 100% lOOrt 100% 100% 100% 100% 23%
Page 8
DOOGAR & ASSOCIATES Chartered Accountant s Independent Audit ors' Review Report on the Q uart erly and Vear to dale l naudi1 ed Sta nd11 lone Financial Resu lts of th e Compnn y pursua nt to Regu lation 33 of th e Scc uril ies a nd [xclrnn ge Board of India (Listing Obligati ons nnd Disclosure Req uire ment s) Regulati ons, 201 Sas amended To Board of Directors Poly Medi cure Limited 232-B, lll rd Floor, Okhla Industrial Estate. Phase-II 1, ew L>elhi- 110020 We have n::viewed the accompany ing statement of unaudi1cd standalone fin uncial results of Poly Medi cure Limited ("the company") for the quarti;:r and half year ended 30th September 2026 attached herewith, being submitted b) the company pursuant to the requirements of Regulations :n of the El3I (L isung Obligat ions and Disclosure Requirements) Regulations, 2015 (a~ amended). This statement is the responsibili ty of the Company' s Managemem and approved by the l3oard of Directors has been compiled from the related interim financial s1a1emcn1s whi ch has been prepared in accordance with Indian Accounti ng Siandard 34 •·Jnterim Fimmcidl Reportin g" (Ind AS 1-t). specified under Section 133 of the t ·ompanies Act. 2013, read with relevant rules i!, ued thereunder and other accounting principles generall)' accepted in India. Our responsibilit y is to i!.~ue a report on these financial statement~ ba-.ed on our review. \ e conducted our review in accordance with the Standard on Review l::.ngagcment (SRE) 24 10, "Review of Interim Financial In formation perfo rmed by the lndepcndent Auditor or the Entit) " 1s,ued by the lnstttute of Chartered Accountants of India . This standard requires that we plan and perform the review to obtain moderate as~urance as to whether the fin ancial statements are free of material misstatement. A review is limi ted primari ly to inquiri es of company personnel and analyti cal procedures applied to financial data and thus provides less assurance than an audi1. We have not performed an audit and accordingl y. " e do 1101 c,prc!>~ an audit opinion. Ba!,cd on our review conducted a, above. nothing has come to our a11c111ion th,11 cau~i.:~ u~ to belie, e that the accompanyin g stateI11i.:nt of unaudited standalone financial result s prepared in accordance with applicab lc m . .:counting standards i.e. Ind A prt:!,cribed under Seclion 133 of the C'ompanic.-s Act , 20 13 read with rekvant rule!> i~sued thereunder and other recognized a1.:counting practices and policies has not disclosed the informati on required tu be disclosed in terms of Regulation 33 of the SEBI (Listing Obligati ons and Disclosur~ Requirements) Regulatiom , :W 15 (as amended) and SEBI Circular dated S'h July. 20 16 including the manner in which it is to be disclosed. or that ii contains any material misstatement. Cha11ercd Ac1:uu111ants Firm Registrati on ~ Madhusudan Agar Partner Membership o. 0 UDI : 26086580PTBSHJ 5044 Place: cw Delhi Date: 05 ovember 2026 13, Community Centre, East of Kailash, New Delhi - 110065 E-mail : client@doogar.com, admin@doogar.com, Website : www.doogar.com Ph. : 011-46579759,41051966, 47037656 Branches at : Mumbai and Agra
Page 9
DOOGAR & ASSOCIATES Chartered Accountants lnd epc ndcn1 A uditors' Review Report o n the Quarterly and Year to Oate na udited Co nso lida ted Financial Res ults of the Co mpan y pu rsuant to Reg ulation 33 of the ·ecurities and Exchange Boan! of India (Listing Obli gations and Disclosure Requirements) Regulati ons, 20 15 as amended To Board of Direct or Poly Medi cure Limited 232-B, lll rd Floor. Okhla Industri al Estate. Phase-Ill, New Delhi- I 10020 1. We have reviewed the accompany ing tatement of naudited Consol idated Financial Re:.ults of Poly Medic ure Limited (" Parent") and its subsidiaries (the parent and its ubsidiaries together referred to as ' the group ') and its share of the pro fi t after tax of its associate for the qua11er and ha lf year ended 30th eptember 2026 (the" tatement"') attached herewi th. being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEOI (List ing Obligauons and Di sc lo ure Requirements) Regulations 20 15 as amended ('the Regulati on'). read v,ith <:;EBI Circular o. CIR/CFD /CMDl /44/20 19 dated March 29. 2019("t he Circular ' ). 2. 1'111 Statement. which is the responsibilit y 01· the Parent' s l anagement and appnned b) the Parent· Board of Director s. has bc::en prepared in accordance \\ ith the recognition and measurement prim.:iples laid down in lnd illn /\ ccounting tandard 34. (Ind AS 34) " Interim Financial Report ing" prescribed under section 133 of the Companies Act, 2013 as amended. read with rele ant rules issued thereunder and other accounting principles generally accepted in India read with the Circular. Our respon~ibility i to e>-pre:,s a conclu!>ion on the Statement based on our review. J. We conducted our review of the statement in accordance wi th the tandard on Re\ ic::w Engagements (SRE) 2410, '·Review of Interim Financial Informati on performed b) the Independent Aud itor of the Entity "' issued by the Institute of Cha11ered Accountants of India. A review of interim ti nancial informati on con ists of makin g inqui ries, primar ily of person!> responsible for financial and accountin g maners. and appi) ing. anal) tical and other re\ ie\\ procedures. A review is substanti ally less in scope thc1 11 an audit conducted in accordance wi th Standards on Auditin g and consequently does not enable u to obtain assurance that we \\OUld become aware of all 1gniti cant matters that might be identified in an audit. According.I) . "e do not expres an audit opini on. We also performed pro1.:edure. in accordance with the Circular i ·sued by the Securnie~ and Exchange Board of India under Regulati on 33(8) of the Regulation, to the e;-.tent applicable. 4. The Statement includes the re ults of the entiti es mentioned in Annex ure I to the statement. 5. We did not review the financial results of one foreign ~ub idiary namely Polymed BraLil LTDA (con olidated) and two \\ hol ly owned subsidiary incorporated in India namely Him ala}an Mineral Waters Private Limited and Plan I Health India Private Lim ited included in rhe con~olidated unaudited financial results, whose fi nancial results with out eliminati on reflects total assets of Rs. 626.90 lacs as at 30th September 2026, total revenue of R .. ii and Rs. ii, total nt:t pro~ oss) after tax of Rs. ( 144. I 3) lacs and Rs. (268.54) lacs. and total cu111 prehensive incomv.,,.,,....,,_._..,.~ . c, • 000$. ~ 0 ~~ - 6'_..-? 13, Community Centre, East of Kailash, New Delhi - 11006 ~ ""New e1ht * E-mail : client@doogar.com, admin@doogar.com, Website • www.do .c ~ Ph.: 011-46579759, 41051966, 47037656 '/'/qrBdAeco~~''ti Branches at : Mumbai and Agra
Page 10
( 144. 13) lacs and Rs. (26 8.54) lacs. for the quarter and period ended 30'11 September 2026 respecti vely. as considered in the consolidated unaudited fin ancial results. The consolid ated unaudited fin ancial results also include the Group's share of profit after tax of Rs. 15 1.65 lacs and Rs. 306.98 lacs. included in quarter and period ended 30111 September 2026 respect ively. as considered in the statement. in respect of one foreign associate. whose financial result s have not been reviewed by us. Th ese fin ancial results are ce1tifi ed by the management of respecti ve companies and our conclusion on the Statement in so far as it relates to the amounts and disclosures in respect of these subsidiaries and associate is based olely on the basis of fi nancial ·tatement as ce11ified and procedures performed by us as stated i11 paragraph 3 above. Our concl11sion on tile statement is 1101 modified in respect of above matter. We did not review the fi nancial results of one foreign subsidiary namely Poly Medicure (La iyang) Co L imi ted, Ch ina. who lly owned subsidiary company of the Company included in the consolidated unaudited fin ancia l results. whose tinancial statements without elim ination ref-lects Iota I assets of Rs. I ,307 .60 lacs as at JO'" September 2026. total revenue of Rs. 187.89 lacs and Rs. 347.57 lacs. total net profit / (loss) after tax of Rs. (2.27) lacs and Rs. (59.59) lacs. and total comprehensive income/ (loss) of Rs. (2.27) lacs and Rs. (59.59 ) lctcs. for the quarter and period ended 30'11 September 2026 respectively and have been I im ited reviev.ed by auditor situated outside India . Our opinion on consolidated fi nancial statements in so for as it relates to the aforesaid subsidiary is based on li mited review repurt u fthe subsidiary. Our con<.:lusion on the statement is not modi fied in respect of above maner. We did not review the Consolidated Financial Statement of one fore ign subsidiary name I) Poly Medicure OV Nethedands. which i11cl udes fi11a11cial statc:nIeI11s of Pla11 I Health SRL Ital) for quarter and period ended 30th June 2026 and Poly Health Med ical Inc. U . Poly Health Limited UK for the quaIt er and period ended 30111 September 2026 and who e finan cial statement wit hout eliminati on ref-lect total assets of Rs. 11,354.36 lacs as at 30111 eptember 2026, total revenue of Rs. 4.540.30 lacs and Rs. 7 .969.55 lacs. Net profit after tax of Rs. 123 .49 lac and Rs. I 64.4 I lacs and total comprehensive inco me/ (loss) of Rs. 123.49 lacs and Rs. I 64.4 I lacs. for the quarter and period ended JO'" September 2026 respectively and have been limited reviewed by auditor siwate d outside India/ in India and also includes financia l statement of Risor Holding B.V. Netherlands (consolidated) and Medistream SA Switzerland (consolidated), whose fi nancial statement without elimin ation refl ect total assets of Rs. 53,293.90 lac as at 30111 September 2026, total revenue of Rs. 6,779.24 lacs and Rs. 14,409.32 lacs. total profit/ (loss) after tax of Rs. ( 1,050.69) lacs and Rs. ( 1,554.96 lacs) and total comprehensive income/ (loss) of Rs. ( 1.050.69) lacs and Rs. ( 1.554 .96 lacs). for the quaIt er and period endt:d JO September 2026 re:spc:cti vt:ly and hc:1ve bc:en n1c:111agemc:nt certifi ed and given effect to in consolidated ti nancial statement~. Our opinion on consolida ted fin ancial statements in so far as it relates to the aforesaid subsidiary i based on limit ed revie,-.. report of three step down subsidiaries and management certi lied financial statements of other step down subsidiaries. Our conclusio n on the statement is not modified in respect of above maner. 6. In respect of subsidiaries and associate located outside India whose finan cial re. ults and other financial information have been prepared in accordance w ith accounting principles generall) accepted in their respecti ve countries and are management ceI1 ified/ I im ited reviewed . The Parent's management has conve1ted the fi nancial result s of such subsidiarie s and associate located outside India from accounti ng rrincip les general ly accepted in their respective countrie. to the accounting principles generally accepted in India. We have reviewed conversion adjustment s made by the parent's management. Our conclusion in so far a it relate to balances and affairs of such sub id iaries and associate located outside India is based on the conversion adjustments prepared by the management of the Parent and reviewed by u . ~ &. ASs0 c:J · OOos. C;. 0 Q:~ - ~., ~ o "- :z rn ~ N Deihl f '} ;:t' ~,.,. ~'I> '1r6,:J Acco~~
Page 11
7. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the fi nancial statements as I im ired reviewed/ certified by the management referred to paragraph 5 above. nothing has come to our attention that cause us to believe that the accompanying statement, prepared in accordance w ith recognition and measurement princip les laid in the aforesaid Indi an Acco unting Standard specified under ection 133 of Companies Act, 20 I 3, as amended, read with relevant rules issued thereunder and other accountin g prin cipl es generall y accepted in India. has not disclosed the informati on required to be disclosed in terms of Regulation. rc:ad with circular, incl uding the manner in which it is to bt: disclosed, or that it contains any matt:rial m isstatemt:nt. For Doogar & Associates Cha11ered Accountants Firm' s Registrat i l-lJ$1'f6i~ :OO - IN ~ Madhusudan Ag Partner \it embership num UDIN: 260865801RYWFN6590 Place: ew Delhi Date: 05 Novembe r 2026
Page 12
Annexure - l List of entities includ ed in the co nsolidated finan cial stntcmc nts for the quarter/ period e nded 30th September, 2026 ,H"e ~s under: Sr. No. Na me of the Company Pare nt Compan y I Poly Medicure L imited Subsidiary 2 Plan I Health India Private Limited(II 3 Poly Medicure (Laiyang) Company Lim ited11l 4 Poly Mcdicure B.v.II1 5 Polymed BraLil L TDA11 l 6 Himalayan Mineral Waters Private Limited 11 1 Step - s ubsidiary 7 Plan I Health SRU 21 8 Risor Holding 8.V _lll 9 Well ing Medica l 13.V.<Jl 10 Pendracare I lolding B.V.(1> I l Pendracare Vasc1ilar B.V _(4l 12 Pendracare International l3.V.'4 ' 13 Med istream SA<2l 14 Citieffe SRU5l I S Citicffe lnc.(6l -16 Citieffe De.<61 17 Polv Health lnc.m - -18 Poly Hea Ith Lim ited(2l 19 Medyn eo Comercio De Produtos Para Saude L TD A171 Assoc iate 20 Ultra For Med ical Products Comoanv (Ultra Med) ( ll Wholly-ow ned subsidiary of Poly Mcdicure Limi ted Cl> Wholly-ow ned subsidi ary of Poly Medicure B.Y . C\l Wholly -owm:d subsidiary of Risor Holding R. V. <4l Wholly-owned subsidiary of Pendracare Holding B. V. < 5l Wholly-ow ned subsidiary of M edistream SA <6> Wholly-owned subsidia,y of Citieffe SRL <7> Wholly-owned subsidia1y of Polymed Brazil L TDA Co untry of incorporation India China ~ Netherland~ Brazil Ind ia Italy Netherlands Netherlands Netherlands etherlancl~ -Netherlands Switzerland Italy USA M exico lJSA UK BraLi I ~ §gyyt